Z16.12 ICD 10 Code is a billable and specific code that can be used to indicate a diagnosis of Extended spectrum beta lactamase (ESBL) resistance for reimbursement purposes. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.
Type 2 excludes for Z16.12 ICD 10 code
- Methicillin resistant Staphylococcus aureus infection in diseases classified elsewhere (B95.62)
Possible back-references that may be applicable or related to Z16.12 ICD10 Code:
- Z00-Z99 Factors influencing health status and contact with health services
- Z16 Resistance to antimicrobial drugs
- Z16 Resistance to antimicrobial drugs
- Z16.1 Resistance to beta lactam antibiotics
- Z16.2 Resistance to other antibiotics
- Z16.3 Resistance to other antimicrobial drugs
Present On Admission (POA Exempt)
Z16.12 ICD 10 code is considered exempt from POA reporting